Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Each blog post aims to inform readers about the health and economic benefits of research.  

Recent Blog Posts

The February issue of The Research Advocate is now online . Highlights from this month include: Senator Roy Blunt (R-MO) and Representative Tom Cole (R-OK) will be honored with the Whitehead Award for Medical Research Advocacy at Research!America's 2016 Advocacy Awards Dinner for increasing investments in research and elevating the importance of medical progress among national priorities. Vice President Biden’s ‘moonshot’ initiative to defeat cancer has received support from many Americans who say they are willing to pay more in taxes to support cancer research, according to a new national public opinion survey commissioned by Research!America. A member spotlight featuring the American...
Dear Research Advocate: As task force meetings for Vice President Biden’s “moonshot” initiative began this week, a new public opinion survey commissioned by Research!America showed that 50% of Americans favor a tax increase to fund cancer research. While this manner of funding the moonshot is not currently on the table, the survey finding underscores the high priority Americans place on curing cancer. The President told Majority Leader McConnell and Speaker Ryan that assuring resources for research, cancer in particular, is one of his five priorities for working across the aisle this year. His FY17 budget proposal -- scheduled for release next Tuesday -- will reportedly request additional...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), recently released a new report, the Action Plan for Lupus Research to assess opportunities for increasing scientific understanding of lupus, which will ultimately lead to safer and more effective treatments and, eventually, curative strategies. The report reflects the current need and gap in lupus research for helping to improve upon a basic understanding of the disease and to identify targets for advancing lupus drug development. Lupus is an unpredictable and misunderstood autoimmune disease that ravages different parts of the body. It is difficult to diagnose...
Dear Research Advocate, If flight cancellations triggered by winter storm Jonas did not dampen plans to travel south for some much needed warmth, the new Centers for Disease Control and Prevention (CDC) travel warnings about the Zika virus might. The President was briefed early this week by CDC Director Tom Frieden, HHS Secretary Sylvia Burwell, and NIAID Director Anthony Fauci in the ‘situation room.’ According to Dr. Fauci, "an extensive research and development effort" to address this emerging concern has already begun. The Zika virus, which may be linked to the development of severe birth defects, is also gaining the attention of major industry members like GSK and Sanofi, who are...
Dear Research Advocate: With great pleasure, we made a big announcement this week -- Chairmen Roy Blunt (R-MO) and Tom Cole (R-OK-04) will be receiving the Whitehead Award at our Annual Awards Dinner on March 16 at the Mellon Auditorium. I hope you will be there to join us in honoring these champions for the tremendous commitment they have shown to advancing medical progress. By now you may have heard the news that the Cures initiative is on the move! The Senate HELP Committee released its plan to consider multiple pieces of legislation that support the same objectives as the House 21st Century Cures Act (HR 6). Senate HELP Committee Chairman Lamar Alexander (R-TN) announced the Committee’s...
Dear Research Advocate, In his final State of the Union address, President Barack Obama spoke about his vision for the future, “For the loved ones we’ve all lost, for the family we can still save, let’s make America the country that cures cancer once and for all. Medical research is critical .” The President has placed Vice President Biden at ‘mission control’ for this ‘moonshot’ to cure cancer, and the Vice President is poised to lead. (See my SOTU statement. ) Historically, presidential articulation has driven the national commitment to science in ways that leapfrog incremental progress by pulling out all the stops. That’s the kind of moment we’re seeing right now, and it is has captured...
The January issue of The Research Advocate is now online . Highlights from this month include: Research!America's policy wish list for 2016, which focuses on a number of important policy priorities to build on the progress achieved last year to combat costly and devastating diseases that are taking a toll on our nation’s health and economy. Federal policy update, including information on the FY16 omnibus bill. Member spotlight featuring the Galveston National Laboratory. Talking points from the International Summit on Human Gene Editing held in Washington, D.C., December 1-3, hosted by the National Academy of Sciences and the National Academy of Medicine. A study published in Annals of...
Dear Research Advocate: As the new year begins we are hard at work building on the momentum created by Congress’ strong support of research in 2015 to ensure that robust funding and pro-innovation policies will be the norm, not the exception, in the years ahead. I applaud the American Cancer Society Cancer Action Network (ACS-CAN) for sponsoring a terrific full page ad in The Washington Post yesterday, offering thanks to Congress and thanks to research for providing new hope to patients and their families. Another group to thank is all the many partners in advocacy -- you! -- who have worked together so effectively to achieve the successes of the last year. Advocacy is indeed a team sport,...
As 2015 comes to an end, let’s revisit the top ten most popular Research!America blog posts of the year (based on page views) that emphasized the importance of communicating the value of research and making research and innovation a higher national priority. We would like to thank our outstanding guest bloggers, including early career scientists, and leaders representing academia, industry, patient groups and scientific societies, who believe in the endless possibilities of scientific discovery, development and delivery to improve our nation’s health. 1) Lessons learned from a workshop on effective science communication April 24 : Our most popular post of the year! Debra Cooper, Ph.D., a...
Dear Research Advocate, As the year draws to a close it is important to reflect on accomplishments made on behalf of patients and their families. We do have a lot to celebrate. Advocates for research for health accomplished not one, but FOUR, major goals: A meaningful increase in federal funding for medical research. The NIH has received an additional $2 billion for FY16, the FDA and CDC saw a 5% increase in funding over FY15 levels, and NSF received an additional $118 million and the freedom to continue their work in the social and behavioral science fields unhindered. If we keep at it, we will look back on these increases as the beginning of a heightened national commitment to science...

Pages

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln